Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.

Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium

1988 • 961 citations

Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny

1980 • 837 citations

Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer

1993 • 526 citations

Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors

1995 • 285 citations

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone

1991 • 281 citations

Mechanisms of cancer metastasis to bone.

1986 • 239 citations

LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASES

1983 • 216 citations

Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas

1983 • 196 citations

Strontium 89 Therapy for the Palliation of Pain Due to Osseous Metastases

1995 • 190 citations

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

1993 • 183 citations

Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma [see comments]

1993 • 134 citations

Clinical Trials in Relapsed Prostate Cancer: Defining the Target

1996 • 129 citations

Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49.

1994 • 121 citations

A radioimmunoassay for the detection of a human tumor‐associated glycoprotein (tag‐72) using monoclonal antibody B72.3

1986 • 110 citations

Bone metastases: improving the therapeutic index.

1994 • 89 citations

Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG‐72)

1986 • 86 citations

Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells.

1992 • 86 citations

Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma.

1995 • 77 citations

Some Limitations of the Radioisotope Bone Scan in Patients With Metastatic Prostatic Cancer

1990 • 74 citations

Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer

1994 • 73 citations

Interferon-Induced Changes in Pharmacokinetics and Tumor Uptake of 111In-Labeled Antimelanoma Antibody 96.5 in Melanoma Patients

1988 • 69 citations

Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells.

1994 • 67 citations

Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells.

1992 • 62 citations

Tumor Associated Glycoprotein-72 is Highly Expressed in Prostatic Adenocarcinomas

1994 • 45 citations

Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons.

1991 • 33 citations

TAG-72 Expression in Primary, Metastatic and Hormonally Treated Prostate Cancer as Defined by Monoclonal Antibody CC49

1995 • 24 citations

Clinical Trials in Prostatic Cancer: Methodology and Controversies

1987 • 14 citations

Effects of Recombinant Human γ-Interferon on Carcinoembryonic Antigen Expression of Human Colon

1992 • 14 citations

Potential for Artifacts in Monitoring for the Detection of Tumor Associated Antigens (TAG-72 and CEA) in Serum from Patients Undergoing MAb-based Diagnostic and Therapeutic Protocols

1990 • 8 citations